Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
ResMed: Long-Term Thesis Remains Unchanged, Rate Buy For Compelling Value
01:00pm, Monday, 29'th Aug 2022
ResMed continues to offer compelling value after a robust set of fourth quarter earnings. RMD saw upsides at the top and bottom line relative to consensus, yet, the stock has been punished from August
Dividend Champion, Contender, And Challenger Highlights: Week Of August 14
04:50am, Sunday, 14'th Aug 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Check out the stocks with dividend changes and upcoming pay dates.
Competitor Recall Continues To Show Opportunities For ResMed
10:34pm, Friday, 12'th Aug 2022 Benzinga
ResMed Inc (NYSE: RMD) posted Q4 sales of $914.7 million, +4% Y/Y (+8% on a constant currency basis), beating the consensus of $912.97 million.
Adjusted EPS reached $1.49, up from $1.35 a year ago.
ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up
07:34pm, Friday, 12'th Aug 2022 Zacks Investment Research
ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.
ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up
05:18pm, Friday, 12'th Aug 2022
ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
02:14pm, Friday, 12'th Aug 2022 Benzinga
Upgrades
Mizuho upgraded the previous rating for Safehold Inc (NYSE:SAFE) from Neutral to Buy. For the second quarter, Safehold had an EPS of $0.37, compared to year-ago quarter EPS of $0.28. At the
ResMed (RMD) Q4 2022 Earnings Call Transcript
12:31am, Friday, 12'th Aug 2022 The Motley Fool
RMD earnings call for the period ending June 30, 2022.
Resmed, Inc. (RMD) CEO Michael Farrell on Q4 2022 Results - Earnings Call Transcript
10:27pm, Thursday, 11'th Aug 2022
Resmed, Inc. (NYSE:RMD ) Q4 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Michael Farrell - CEO & Director Brett Sanderc
ResMed (RMD) Q4 Earnings Beat Estimates
09:25pm, Thursday, 11'th Aug 2022 Zacks Investment Research
ResMed (RMD) delivered earnings and revenue surprises of 0.68% and 0.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ResMed (RMD) Q4 Earnings Beat Estimates
06:49pm, Thursday, 11'th Aug 2022
ResMed (RMD) delivered earnings and revenue surprises of 0.68% and 0.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ResMed Q4 Preview: Rebound Quarter Inbound?
10:11pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
RMD has primarily exceeded the Zacks Consensus EPS Estimate. However, the company registered an 8% bottom-line miss in its latest quarter.
Nephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Nephros Inc. (NEPH) delivered earnings and revenue surprises of 14.29% and 6.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ResMed Q4 Preview: Rebound Quarter Inbound?
07:33pm, Wednesday, 10'th Aug 2022
RMD has primarily exceeded the Zacks Consensus EPS Estimate. However, the company registered an 8% bottom-line miss in its latest quarter.
Last Peak Week Of Q2 Earnings Season Is Here, Then Come The Retailers
02:26pm, Monday, 08'th Aug 2022 Investing.comThese Are The 10 Biggest Companies Revealing Earnings Next Week
09:15pm, Friday, 05'th Aug 2022
About 56% of the S&P 500 companies have reported their quarterly earnings as of last week.
